Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

Cited in blog · Diabetes, Obesity and Metabolism, 24(8), 1553–1564. · 2022

Wilding JPH, et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564.